Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy
Author:
Affiliation:
1. National Hospital for Neurology and Neurosurgery; MRC Centre for Neuromuscular Diseases; PO Box 114 Queen Square London UK WC1N 3BG
2. Janakpuri Superspecialty Hospital; Department of Neurology; C-2/B, Janakpuri New Delhi Delhi India 110058
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD002062.pub3/fullpdf
Reference62 articles.
1. Prednisone improves chronic inflammatory polyradiculoneuropathy more than no treatment;Dyck;Annals of Neurology,1982
2. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment;Eftimov;Neurology,2012
3. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial;Schaik;Lancet Neurology,2010
4. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone;Lopate;Archives of Neurology,2005
5. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial;Nobile-Orazio;Lancet Neurology,2012
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies;Journal of Neurology, Neurosurgery & Psychiatry;2024-05-10
2. Serum B-cell activating factor is not a potential biomarker for disease activity in chronic inflammatory demyelinating polyneuropathy;Journal of Neuroimmunology;2023-09
3. Clinical outcome of CIDP one year after start of treatment: a prospective cohort study;Journal of Neurology;2021-06-26
4. Inflammatory polyradiculoneuropathies: Clinical and immunological aspects, current therapies, and future perspectives;European Journal of Inflammation;2020-01
5. Konsensuspapier zum Einsatz der therapeutischen Apherese in der Neurologie;DGNeurologie;2019-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3